1. Yun, Hyeseon, Jeong, Hong-Rae, Kim, Do Yeon, Bae, SeungGeon, Jin, Dong-Hoon. 2024. Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. In Journal of cellular and molecular medicine, 28, e18104. doi:10.1111/jcmm.18104. https://pubmed.ncbi.nlm.nih.gov/38183356/
2. Wen, Ru M, Qiu, Zhengyuan, Marti, G Edward W, Pitteri, Sharon J, Brooks, James D. 2024. AZGP1 deficiency promotes angiogenesis in prostate cancer. In Journal of translational medicine, 22, 383. doi:10.1186/s12967-024-05183-x. https://pubmed.ncbi.nlm.nih.gov/38659028/
3. Cao, Runyi, Ke, Min, Wu, Qingxin, Lu, Shan, Liu, Ping. 2019. AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis. In Journal of cellular physiology, 234, 17444-17458. doi:10.1002/jcp.28366. https://pubmed.ncbi.nlm.nih.gov/30820960/
4. Wei, Xin, Liu, Xi, Tan, Changhong, Deng, Fen, Chen, Lifeng. 2019. Expression and Function of Zinc-α2-Glycoprotein. In Neuroscience bulletin, 35, 540-550. doi:10.1007/s12264-018-00332-x. https://pubmed.ncbi.nlm.nih.gov/30610461/
5. Liu, Jiayong, Han, Haibo, Fan, Zhengfu, Li, Shu, Ji, Jiafu. 2018. AZGP1 inhibits soft tissue sarcoma cells invasion and migration. In BMC cancer, 18, 89. doi:10.1186/s12885-017-3962-5. https://pubmed.ncbi.nlm.nih.gov/29357838/